-transparent.png){kind=logo}
The short-acting hypnotic, triazolam 0.5 mg, was compared in a 7-day double-blind study with the longer acting drug, nitrazepam 5 mg. Of the 60 patients enrolled, 29 in each drug treatment group completed the study and were evaluated. All significant differences found favoured triazolam. On the first night, triazolam was found to be significantly more effective than nitrazepam in inducing and maintaining sleep and in increasing its overall duration. The patients' subjective preference, reflecting the depth of sleep experienced and the effect of the medication, reached highly significant levels in favour of triazolam. Later in the study the differences between the drugs disappeared although the depth of sleep as judged in the study was better with triazolam.
L E Dahl, and
S J Dencker, and
L Lundin, and
H Kullingsjö
April 1993,
The Annals of pharmacotherapy,
L E Dahl, and
S J Dencker, and
L Lundin, and
H Kullingsjö
November 1980,
Acta psychiatrica Scandinavica,
L E Dahl, and
S J Dencker, and
L Lundin, and
H Kullingsjö
January 1978,
The Journal of international medical research,
L E Dahl, and
S J Dencker, and
L Lundin, and
H Kullingsjö
March 1983,
Acta psychiatrica Scandinavica,
L E Dahl, and
S J Dencker, and
L Lundin, and
H Kullingsjö
September 1975,
Clinical pharmacology and therapeutics,
L E Dahl, and
S J Dencker, and
L Lundin, and
H Kullingsjö
July 1981,
The Journal of clinical psychiatry,
L E Dahl, and
S J Dencker, and
L Lundin, and
H Kullingsjö
April 1986,
The British journal of clinical practice,
L E Dahl, and
S J Dencker, and
L Lundin, and
H Kullingsjö
January 1982,
International pharmacopsychiatry,
L E Dahl, and
S J Dencker, and
L Lundin, and
H Kullingsjö
January 1983,
Pharmacology,
L E Dahl, and
S J Dencker, and
L Lundin, and
H Kullingsjö
January 1994,
International clinical psychopharmacology,
